Business Economy


Lupin gets US FDA approval for multiple sclerosis tablet

Chennai, Dec 5 (UNI) Pharmaceutical major Lupin Ltd on Friday announced that it has received tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Siponimod Tablets, 0.25 mg, 1 mg, and 2 mg.
This product would be manufactured at Lupin’s Pithampur facility in India.
Siponimod Tablets, 0.25 mg, 1 mg, and 2 mg are bioequivalent to Mayzent Tablets, 0.25 mg, 1 mg, and 2 mg of Novartis Pharmaceuticals Corporation, and indicated for the treatment of relapsing forms of Multiple Sclerosis (MS), to include clinically isolated syndrome, relapsing remitting disease, and active secondary progressive disease, in adults.
Siponimod Tablets (RLD Mayzent) had estimated annual sales of USD 195 million in the US, the company said.
UNI VJ VAN RKM
More News

Telangana govt, Blaize iign MoU at Davos to drive breakthrough Innovation in Applied AI

24 Jan 2026 | 9:57 PM

Hyderabad/ Davos, Jan 24 (UNI) The Telangana government and Blaize Inc. have signed a non-binding Memorandum of Understanding (MoU) at the ongoing World Economic Forum in Davos, marking a significant step toward advancing applied AI solutions.

see more..

Telangana, Journey partner to launch AI-focused design center of excellence

24 Jan 2026 | 9:23 PM

Hyderabad/Davos, Jan 24 (UNI) : The Government of Telangana, via its AI innovation arm Aikam, has entered a strategic collaboration with global design and innovation firm Journey Corporate Holdings, LLC to establish a Center of Excellence (CoE) for AI-driven design in Hyderabad.

see more..

UNI Special: Dreams vs Deadlines: Budget Time for Action

24 Jan 2026 | 6:27 PM

By BN Kumar
Mumbai, Jan 24 (UNI) As India heads into another union Budget cycle, the gap between policy, ambition and measurable delivery is drawing closer scrutiny from economists, investors and policy analysts.

see more..

JSW Steel Q3FY26 profit jumps by 198 per cent to Rs 2,139 cr

24 Jan 2026 | 5:47 PM

Mumbai, Jan 24 (UNI) JSW Steel has officially announced that it has posted a 198 per cent jump in its consolidated net profit to Rs 2,139 crore in the third quarter of the financial year 2025-26 (Q3FY26), as compared to a profit of Rs 717 crore during the same period last year.

see more..

FIEO urges Govt to address cost pressures, shipping gaps and R&D incentives in union Budget

24 Jan 2026 | 12:53 AM

Hyderabad/New Delhi, Jan 23 (UNI) The Federation of Indian Export Organisations (FIEO) on Friday called on the government to take urgent measures in the union Budget 2026 to enhance the cost competitiveness of Indian exporters, strengthen logistics resilience and boost innovation-led growth.

see more..